Brain Tyrosine Depletion Attenuates Haloperidol-induced Striatal Dopamine Release in Vivo and Augments Haloperidol-induced Catalepsy in the Rat

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2003 Oct 31

PMID 14586541

Citations 10

Authors

George E Jaskiw

Rodolfo Bongiovanni

Affiliations

Soon will be listed here.

Abstract

Rationale: There are conflicting reports as to whether alterations in tyrosine levels affect functional indices of striatal dopamine (DA) transmission. Since the DA antagonist haloperidol (HAL) increases striatal DA release and induces catalepsy through its actions on striatal DA systems, it provides a useful paradigm to assess both neurochemical and behavioral effects of lowering brain tyrosine levels.

Objectives: To determine how brain tyrosine depletion affects HAL-induced catalepsy and striatal DA release in awake, freely moving rats.

Methods: In male rats, a control or tyrosine- and phenylalanine-free neutral amino acid solution NAA(-) (IP) was administered 30-60 min prior to HAL (IP). In one cohort, striatal microdialysate was assayed for DA levels. In a parallel cohort, catalepsy was measured using the bar test.

Results: NAA (-) reduced striatal tyrosine levels by 60%. The latter did not affect basal striatal DA release, but consistently delayed the attainment of maximal HAL-induced (0.19 mg/kg and 0.25 mg/kg SC) striatal DA release; the latter was abolished by administration of tyrosine. NAA(-) also potentiated HAL-induced catalepsy.

Conclusions: Acute brain tyrosine depletion attenuates HAL-induced striatal DA release and potentiates haloperidol-induced catalepsy. Both effects can be reversed by administration of tyrosine. Overall, the data indicate that tyrosine depletion affects both neurochemical and behavioral indices of striatal DA release.

Citing Articles

Dopamine Improves Low Gamma Activities in the Dorsal Striatum of Haloperidol-induced Motor Impairment Mice.

Reakkamnuan C, Cheaha D, Kumarnsit E, Samerphob N In Vivo. 2023; 37(1):304-309.

PMID: 36593045 PMC: 9843765. DOI: 10.21873/invivo.13080.

L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat.

Brodnik Z, Double M, Espana R, Jaskiw G Neuropharmacology. 2017; 123:159-174.

PMID: 28571714 PMC: 5544352. DOI: 10.1016/j.neuropharm.2017.05.030.

Acute phenylalanine/tyrosine depletion of phasic dopamine in the rat brain.

Shnitko T, Taylor S, Stringfield S, Zandy S, Cofresi R, Doherty J Psychopharmacology (Berl). 2016; 233(11):2045-2054.

PMID: 26944052 PMC: 4864125. DOI: 10.1007/s00213-016-4259-0.

Dopamine, norepinephrine, and the management of sensorimotor bindings: individual differences in updating of stimulus-response episodes are predicted by DAT1, but not DBH5'-ins/del.

Colzato L, Zmigrod S, Hommel B Exp Brain Res. 2013; 228(2):213-20.

PMID: 23681294 DOI: 10.1007/s00221-013-3553-x.

Presynaptic regulation of extracellular dopamine levels in the medial prefrontal cortex and striatum during tyrosine depletion.

Brodnik Z, Double M, Jaskiw G Psychopharmacology (Berl). 2013; 227(2):363-71.

PMID: 23371490 DOI: 10.1007/s00213-013-2977-0.

References

Kapatos G, Zigmond M . Dopamine biosynthesis from L-tyrosine and L-phenylalanine in rat brain synaptosomes: preferential use of newly accumulated precursors. J Neurochem. 1977; 28(5):1109-19. DOI: 10.1111/j.1471-4159.1977.tb10675.x. View

McTavish S, McPherson M, Sharp T, Cowen P . Attenuation of some subjective effects of amphetamine following tyrosine depletion. J Psychopharmacol. 1999; 13(2):144-7. DOI: 10.1177/026988119901300205. View

Wurtman R, Larin F, Mostafapour S, Fernstrom J . Brain catechol synthesis: control by train tyrosine concentration. Science. 1974; 185(4146):183-4. DOI: 10.1126/science.185.4146.183. View

During M, Acworth I, Wurtman R . Dopamine release in rat striatum: physiological coupling to tyrosine supply. J Neurochem. 1989; 52(5):1449-54. DOI: 10.1111/j.1471-4159.1989.tb09192.x. View

Pucak M, Grace A . Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J Pharmacol Exp Ther. 1994; 271(3):1181-92. View

Harmer C, McTavish S, Clark L, Goodwin G, Cowen P . Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology (Berl). 2001; 154(1):105-11. DOI: 10.1007/s002130000613. View

Dunstan R, Broekkamp C, Lloyd K . Involvement of caudate nucleus, amygdala or reticular formation in neuroleptic and narcotic catalepsy. Pharmacol Biochem Behav. 1981; 14(2):169-74. DOI: 10.1016/0091-3057(81)90239-2. View

Biggio G, Porceddu M, Gessa G . Decrease of homovanillic, dihydroxyphenylacetic acid and cyclic-adenosine-3',5'-monophosphate content in the rat caudate nucleus induced by the acute administration of an aminoacid mixture lacking tyrosine and phenylalanine. J Neurochem. 1976; 26(6):1253-5. DOI: 10.1111/j.1471-4159.1976.tb07014.x. View

Scarna A, Gijsman H, McTavish S, Harmer C, Cowen P, Goodwin G . Effects of a branched-chain amino acid drink in mania. Br J Psychiatry. 2003; 182:210-3. DOI: 10.1192/bjp.182.3.210. View

10.

Richardson M, Bevans M, Read L, Chao H, Clelland J, Suckow R . Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men. Am J Psychiatry. 2003; 160(6):1117-24. DOI: 10.1176/appi.ajp.160.6.1117. View

11.

Breier A, Su T, Saunders R, Carson R, Kolachana B, de Bartolomeis A . Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A. 1997; 94(6):2569-74. PMC: 20129. DOI: 10.1073/pnas.94.6.2569. View

12.

Sanberg P . Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature. 1980; 284(5755):472-3. DOI: 10.1038/284472a0. View

13.

McTavish S, Cowen P, Sharp T . Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology (Berl). 1999; 141(2):182-8. DOI: 10.1007/s002130050823. View

14.

Fusa K, Saigusa T, Koshikawa N, Cools A . Tyrosine-induced release of dopamine is under inhibitory control of presynaptic dopamine D2 and, probably, D3 receptors in the dorsal striatum, but not in the nucleus accumbens. Eur J Pharmacol. 2002; 448(2-3):143-50. DOI: 10.1016/s0014-2999(02)01911-8. View

15.

Jaskiw G, Collins K, Pehek E, Yamamoto B . Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study. Neuropsychopharmacology. 2001; 25(1):149-56. DOI: 10.1016/S0893-133X(01)00220-2. View

16.

Joh T, Park D, Reis D . Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP-dependent protein kinase: mechanism of enzyme activation. Proc Natl Acad Sci U S A. 1978; 75(10):4744-8. PMC: 336196. DOI: 10.1073/pnas.75.10.4744. View

17.

Janssen P, NIEMEGEERS C, SCHELLEKENS K . IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS. Arzneimittelforschung. 1965; 15:104-17. View

18.

Wadenberg M, Soliman A, VanderSpek S, Kapur S . Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology. 2001; 25(5):633-41. DOI: 10.1016/S0893-133X(01)00261-5. View

19.

Zetterstrom T, Sharp T, Ungerstedt U . Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol. 1984; 106(1):27-37. DOI: 10.1016/0014-2999(84)90674-5. View

20.

McTavish S, Callado L, Cowen P, Sharp T . Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo. J Psychopharmacol. 2000; 13(4):379-84. DOI: 10.1177/026988119901300408. View